MMP2 Protein

📖 Wiki Page

protein871 wordssynced 2026-04-02

MMP2 Protein

Introduction

Mmp2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox .infobox-protein"> [@sternlicht2001]
<table> [@yong2001]
<tr><th colspan="2">MMP2 Protein</th></tr> [@brkic2015]
<tr><td><b>Protein Name</b></td><td>Matrix Metalloproteinase-2</td></tr> [@cauwe2009]
<tr><td><b>Gene</b></td><td>[MMP2](/genes/mmp2)</td></tr>
<tr><td><b>UniProt ID</b></td><td>[P08253](https://www.uniprot.org/uniprot/P08253)</td></tr>
<tr><td><b>PDB IDs</b></td><td>1CK7, 1EAK, 1G5K</td></tr>
<tr><td><b>Molecular Weight</b></td><td>73.9 kDa</td></tr>
<tr><td><b>Subcellular Localization</b></td><td>Extracellular matrix, Cell surface</td></tr>
<tr><td><b>Protein Family</b></td><td>MMP family (gelatinases)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's" style="color:#ef9a9a">ALZHEIMER'S</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">400 edges</a></td>
</tr>
</table>
</div>

Overview

...

MMP2 Protein

Introduction

Mmp2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

The MMP-2 (Matrix Metalloproteinase-2) protein, also known as gelatinase A, is a zinc-dependent endopeptidase that degrades extracellular matrix components. MMP-2 is secreted as a proenzyme (pro-MMP-2) and activated by proteolytic cleavage. In the brain, MMP-2 regulates synaptic plasticity, [blood-brain barrier](/entities/blood-brain-barrier) remodeling, and neuroinflammation. While MMP-2 can contribute to [amyloid-beta](/proteins/amyloid-beta) degradation, it also participates in pathological tissue remodeling in Alzheimer's disease. In Parkinson's disease, MMP-2 is involved in dopaminergic neuron survival and disease progression.

MMP-2 (gelatinase A) is a zinc-dependent endopeptidase that degrades extracellular matrix components and is involved in tissue remodeling and neuroinflammation.

Structure

MMP2 is a 660-amino acid protein with a signal peptide (1-20), propeptide (21-84) containing a cysteine switch, catalytic domain (85-211) with zinc-binding motif HEXGHNL, fibronectin type II repeats (211-438) for gelatin binding, hinge region (439-469), and hemopexin domain (470-660). The propeptide maintains latency until cleaved for activation.

Normal Function

MMP-2 degrades gelatin (denatured collagen), type IV collagen, elastin, and other ECM components. It is secreted as a proenzyme (pro-MMP-2) and activated by membrane-type MMPs (MT1-MMP/MMP14). MMP-2 is involved in tissue remodeling, wound healing, blood-brain barrier (BBB) breakdown, synaptic plasticity, and neuroinflammation. It plays roles in Aβ degradation in AD and dopaminergic neuron survival in PD.

Role in Disease

Elevated MMP-2 is seen in AD (associated with amyloid pathology and BBB dysfunction), PD (dopaminergic region), MS (active lesions), and after stroke/TBI (contributes to secondary damage). MMP-2 deficiency worsens outcomes in some injury models.

Therapeutic Targeting

Broad-spectrum MMP inhibitors (batimastat, marimastat) failed in cancer trials due to side effects. Selective MMP-2 inhibitors are being developed. Natural compounds (tetrahydroxy stilbene, ebselen) have shown MMP-2 modulating activity. Timing and context-specific effects complicate therapeutic targeting.

Background

The study of Mmp2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt: P08253](https://www.uniprot.org/uniprot/P08253)
[PDB: 1CK7, 1EAK, 1G5K](https://www.ebi.ac.uk/pdbe/search?q=MMP2)
[NCBI Protein: MMP2](https://www.ncbi.nlm.nih.gov/protein/?term=MMP2)

Expression Pattern

Tissue Distribution

MMP-2 is widely expressed in various tissues:

Brain: Neurons, astrocytes, microglia, endothelial cells
Connective tissue: Fibroblasts, chondrocytes
Muscle: Smooth muscle cells, skeletal muscle
Vascular: Endothelial cells, vascular smooth muscle
Immune cells: Macrophages, neutrophils

Brain Region Specificity

In the brain, MMP-2 expression is particularly high in:

Hippocampal neurons (CA1, CA3)
Cerebral cortex pyramidal neurons
Cerebellar Purkinje cells
Hypothalamic nuclei
Subventricular zone (neurogenic niche)

Molecular Mechanisms

Activation Cascade

MMP-2 activation requires a complex cascade:

[
MMP-2 degrade- Fibronectin: ECM glycoprotein

Aggrecan: Cartilage proteoglycan
IL-1β: Proinflammatory cytokine
TNF-α precursor: Inflammatory mediator

Role in Neurodegeneration

Alzheimer's Disease

MMP-2 has complex roles in AD:

Protective Effects:

Degrades Aβ peptides
Clears amyloid deposits
Promotes Aβ clearance across BBB

Pathological Effects:

Degrades synaptic proteins
Disrupts blood-brain barrier
Promotes neuroinflammation
Facilitates tau pathology spread

Parkinson's Disease

In PD, MMP-2 modulates:

Dopaminergic neuron survival: Via neurotrophic factor processing
α-Synuclein aggregation: Interaction with aggregation pathway
Neuroinflammation: Glial activation state
Blood-brain barrier integrity: Permeability changes

Amyotrophic Lateral Sclerosis

MMP-2 in ALS:

Elevated in spinal cord of ALS patients
Contributes to motor neuron injury
Facilitates inflammatory cell infiltration
Potential therapeutic target

Therapeutic Targeting

MMP-2 Inhibitors

| Compound | Type | Status | Notes |
|----------|------|--------|-------|
| Batimastat | Broad-spectrum | Preclinical | Poor bioavailability |
| Marimastat | Broad-spectrum | Clinical trials | GI side effects |
| Selective inhibitors | MMP-2 specific | Research | In development |

Challenges

Broad-spectrum inhibitors cause side effects
Timing of intervention critical
Compensatory upregulation possible

Biomarkers

MMP-2 levels as potential biomarkers:

CSF MMP-2: Elevated in AD, PD
Blood MMP-2: Peripheral marker
Activity ratios: MMP-2/TIMP balance

Animal Models

MMP-2 knockout mice: Protected from BBB damage after stroke
Transgenic MMP-2 overexpression: Increased neuroinflammation
AAV-mediated MMP-2: Modulates synaptic plasticity

References

[Nagase H, Woessner JF, Matrix metalloproteinases (1999)](https://pubmed.ncbi.nlm.nih.gov/10419415/)

[Sternlicht MD, Werb Z, How MMPs regulate cell behavior (2001)](https://pubmed.ncbi.nlm.nih.gov/11687497/)

[Yong VW, et al, Metalloproteinases in neurodegeneration (2001)](https://pubmed.ncbi.nlm.nih.gov/11433377/)

[Brkic M, et al, MMP2 in Alzheimer's disease (2015)](https://pubmed.ncbi.nlm.nih.gov/25753823/)

[Cauwe B, et al, MMPs in ALS (2009)](https://pubmed.ncbi.nlm.nih.gov/19643024/)

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

[SASP-Mediated Cholinergic Synapse Disruption](/hypothesis/h-1acdd55e) — <span style="color:#ffd54f;font-weight:600">0.56</span> · Target: MMP2/MMP9

📖 View canonical wiki page →

MMP2 Protein

MMP2 Protein

Introduction

Overview

MMP2 Protein

Introduction

Overview

Structure

Normal Function

Role in Disease

Therapeutic Targeting

Background

See Also

External Links

Expression Pattern

Tissue Distribution

Brain Region Specificity

Molecular Mechanisms

Activation Cascade

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Therapeutic Targeting

MMP-2 Inhibitors

Challenges

Biomarkers

Animal Models

References

Related Hypotheses